Boston Scientific (BSX) Non-Current Assets (2009 - 2026)
Boston Scientific's (BSX) quarterly Non-Current Assets came in at $37.2 billion in Q2 2026, up 8.15% year-over-year from $34.4 billion in Q2 2025, and up 4.42% quarter-over-quarter from $35.7 billion in Q1 2026.
Analysis
Boston Scientific (BSX) Non-Current Assets (2009 - 2026) Analysis & Trends
Boston Scientific has disclosed Non-Current Assets across 18 years of filings, most recently posting $37.2 billion for Q2 2026.
- In Q2 2026, Non-Current Assets rose 8.15% year-over-year to $37.2 billion; the TTM figure through Jun 2026 stood at $142.5 billion (up 10.41% YoY), while the FY2025 annual figure was $34.9 billion, up 7.4% from the prior year.
- Non-Current Assets came in at $37.2 billion for Q2 2026 at Boston Scientific, up from $35.7 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $37.2 billion in Q2 2026 to a low of $26.7 billion in Q4 2022.
- Average Non-Current Assets over 5 years is $30.4 billion, with a median of $28.6 billion recorded in 2023.
- Year-over-year, Non-Current Assets slipped 0.31% in 2023 and gained 22.48% in 2025.
- Over 5 years, Non-Current Assets stood at $26.7 billion in 2022, then rose by 7.16% to $28.6 billion in 2023, then advanced by 13.46% to $32.5 billion in 2024, then climbed by 7.4% to $34.9 billion in 2025, then gained by 6.78% to $37.2 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $37.2 billion in Q2 2026, $35.7 billion in Q1 2026, and $34.9 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 17.70 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.24 Bn |
| Mar 31, 2026 | 35.67 Bn |
| Dec 31, 2025 | 34.88 Bn |
| Sep 30, 2025 | 34.67 Bn |
| Jun 30, 2025 | 34.44 Bn |
| Mar 31, 2025 | 32.81 Bn |
| Dec 31, 2024 | 32.48 Bn |
| Sep 30, 2024 | 29.32 Bn |
| Jun 30, 2024 | 28.12 Bn |
| Mar 31, 2024 | 28.48 Bn |
| Dec 31, 2023 | 28.62 Bn |
| Sep 30, 2023 | 27.54 Bn |
| Jun 30, 2023 | 27.72 Bn |
| Mar 31, 2023 | 27.19 Bn |
| Dec 31, 2022 | 26.71 Bn |
| Sep 30, 2022 | 26.80 Bn |
| Jun 30, 2022 | 27.11 Bn |
| Mar 31, 2022 | 27.27 Bn |
| Dec 31, 2021 | 25.91 Bn |
| Sep 30, 2021 | 25.65 Bn |